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X-linked adrenoleukodystrophy (X-ALD) is caused by a
defect in the gene ABCD1, which maps to Xq28 and codes
for a peroxisomal membrane protein that is a member of
the ATP-binding cassette transporter superfamily. X-ALD
is panethnic and affects approximately 1:20,000 males.
This disease characterized by progressive neurologic
dysfunction, occasionally associated with adrenal
insufficiency.
We aim to describe the clinical, laboratory and cerebral
MRI characteristics of Vietnamese patients with X-ALD
and to identify mutations of ABCD1 in these cases. Clini-
cal features, biochemical finding and cerebral MRI lesions
of 9 cases from 7 unrelated familes were studied. Genomic
DNA from these patients was extracted using standard
procedures from the peripheral blood leukocytes. Muta-
tion analysis of ABCD1 was performed using Polymerase
chain reaction (PCR) and DNA direct sequencing.
Among these patients, two families had two children
with X-ALD, the others were unrelated but one case had
family history of X-ALD (his maternal grand mother has a
sister whose two sons having paralysis for more than 1
year, hyper-pigmentation and died at the age of 7 and 12
yrs). Endocrinology symptoms of adrenal insufficiency
were observed in 8/9 cases; 7/9 cases showed neurological
symptoms of cerebral ALD or adrenomyeloneuropathy;
2/9 cases had only symptoms of chronic adrenal insuffi-
ciency and no neurological symptoms until 12 and 5
years of age, respectively. 8/9 cases had serum cortisole
and ACTH measured confirmed adrenal insufficiency.
8/8 cases showed increased plasma VLCFA. Neuroima-
ging studies (cerebral MRI) showed classical posterior
pattern in 7 cases who had neurological symptoms
and normal pattern in 2 cases without neurological
manifestations. We identified 7 different mutations of
ABCD1 in 9 patients. Of which, four novel mutations
[c.1202G>T (p.Arg401Trp); c.1208T>A (p.Met403Lys);
IVS8+28-551bp del; and the extent of deletion included
between IVS1+505 and IVS2+1501, containing whole
the exon 2 (4243bp), plus insertion of 79bp from BAP31
and 8bp from unknown origin in this deleted region]
were identified in four unrelated patients with neuro-
logical symptoms. The reported mutation c.1628C>T
(p.Pro543Leu) was identified in two cases (sibling:
elder had no neurological symptoms and younger had
progressive neurological disability). The reported
mutation c.1553G>A (p.Arg518Gln) was found in a
boy without neurogical symptoms at 5 years of age.
The reported mutation c.1552 C>T (p.Arg518Trp) was
identified in two cases (sibling: both have adrenal
insufficiency and neurogical symptoms).
For the first time, mutations in ABCD1 are identified
in X-ALD Vietnamese patients. Despite many mutations
having been identified in patients with these clinical
phenotypes, the genotype-phenotype correlations have
not been clarified.
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